GeorgeMRodgersMD

Oncology • Salt Lake City, UT

Hematologic Oncology

Professor of Medicine, University Utah

Join to view full profile

Dr. Rodgers is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Rodgers' full profile

Already have an account?

Office
1950 Circle Of Hope Dr
Salt Lake City, UT 84112
Phone+1 801-581-2121

Education & Training

University of California (San Francisco)Fellowship, Hematology and Medical Oncology, 1979 - 1982
Baylor College of MedicineResidency, Internal Medicine, 1976 - 1979
Tulane University School of MedicineClass of 1976

Certifications & Licensure

CA State Medical License 1978 - Present
UT State Medical License 1988 - 2026
FL State Medical License 2014 - 2022
LA State Medical License 1976 - 1987
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Pathology Hematology

Clinical Trials

A Efficacy and Safety Study of R935788 in the Treatment of Persistent/Chronic Immune Thrombocytopenic Purpura (ITP) Start of enrollment: 2014 Jul 14
Completed
Phase 3

Publications & Presentations

PubMed

109 citations
Elevated factor XI activity levels are associated with an increased odds ratio for cerebrovascular events.
David T. Yang, Michele M. Flanders, Hyunhee Kim, George M. Rodgers
American Journal of Clinical Pathology. 2006-09-01
27 citations
ALPK1 missense pathogenic variant in five families leads to ROSAH syndrome, an ocular multisystem autosomal dominant disorder.
Lloyd B. Williams, Asif Javed, Amin Sabri, Denise J. Morgan, Chad D. Huff
Genetics in Medicine. 2019-04-10
62 citations
Superwarfarin poisoning: a report of two cases and review of the literature.
Joseph E. Spahr, J. Scott Maul, George M. Rodgers
American Journal of Hematology. 2007-07-01

Abstracts/Posters

Von Willebrand Disease Minimize Menorrhagia (VWDMin) Trial
George M. Rodgers, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Pharmacoeconomic Analysis of Ideal Vs. Actual Body Weight-Based Treatment for Adult Persons with Hemophilia _Clinically Relevant Abstract
George M. Rodgers, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Press Mentions

UCLA Jonsson Comprehensive Cancer Center Researchers at ASH 2021 Annual Meeting and ExpositionDecember 14th, 2021
(Epoetin Alfa-Epbx) Approved by U.S. FDAMay 15th, 2018

Grant Support

Efficacy Of Enoxaparin In Trealment Of Deep Vein ThrombosisNational Center For Research Resources1995–1996
Regulation Of Coagulation By Vascular CellsNational Heart, Lung, And Blood Institute1985–1986
Nhlbi Clinical Investigator Award ProgramNational Heart, Lung, And Blood Institute1985–1986